The most significant condition linked to mutations in the COL4A5 gene is Alport syndrome. This syndrome is primarily characterized by progressive kidney disease, hearing loss, and eye abnormalities. It can lead to end-stage renal disease (ESRD) at an early age if not managed appropriately.
